Download presentation
Presentation is loading. Please wait.
Published byZoé Germain Modified over 5 years ago
1
A Phase I Trial: Dose Escalation of Melphalan in the “BEAM” Regimen Using Amifostine Cytoprotection
Gordon L. Phillips, Steven H. Bernstein, Jane L. Liesveld, Camille N. Abboud, Michael W. Becker, Louis S. Constine, J.J. Ifthikharuddin, John E. Loughner, Laurie A. Milner, David H. Vesole, Jonathan W. Friedberg Biology of Blood and Marrow Transplantation Volume 17, Issue 7, Pages (July 2011) DOI: /j.bbmt Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 Study group. (A) PFS. (B) OS.
Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions
3
Figure 2 “Control” group. (A) PFS. (B) OS.
Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.